Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?

被引:28
作者
Eriksson, U [1 ]
Opravil, M [1 ]
Amann, FW [1 ]
Schaffner, A [1 ]
机构
[1] Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland
关键词
D O I
10.1097/00002030-199815000-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2079 / 2080
页数:2
相关论文
共 13 条
[1]   Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease [J].
Cameron, DW ;
Heath-Chiozzi, M ;
Danner, S ;
Cohen, C ;
Kravcik, S ;
Maurath, C ;
Sun, E ;
Henry, D ;
Rode, R ;
Potthoff, A ;
Leonard, J .
LANCET, 1998, 351 (9102) :543-549
[2]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[3]   PLASMA-LIPIDS IN HIV-INFECTED PATIENTS - A PROSPECTIVE-STUDY IN 95 PATIENTS [J].
CONSTANS, J ;
PELLEGRIN, JL ;
PEUCHANT, E ;
DUMON, MF ;
PELLEGRIN, I ;
SERGEANT, C ;
SIMONOFF, M ;
BROSSARD, G ;
BARBEAU, P ;
FLEURY, H ;
CLERC, M ;
LENG, B ;
CONRI, C .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (06) :416-420
[4]   Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study [J].
Constans, J ;
Marchand, JM ;
Conri, C ;
Peuchant, E ;
Seigneur, M ;
Rispal, P ;
Lasseur, C ;
Pellegrin, JL ;
Leng, B .
ANNALS OF MEDICINE, 1995, 27 (06) :683-685
[5]   A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].
DANNER, SA ;
CARR, A ;
LEONARD, JM ;
LEHMAN, LM ;
GUDIOL, F ;
GONZALES, J ;
RAVENTOS, A ;
RUBIO, R ;
BOUZA, E ;
PINTADO, V ;
AGUADO, AG ;
DELOMAS, JG ;
DELGADO, R ;
BORLEFFS, JCC ;
HSU, A ;
VALDES, JM ;
BOUCHER, CAB ;
COOPER, DA ;
GIMENO, C ;
CLOTET, B ;
TOR, J ;
FERRER, E ;
MARTINEZ, PL ;
MORENO, S ;
ZANCADA, G ;
ALCAMI, J ;
NORIEGA, AR ;
PULIDO, F ;
GLASSMAN, HN .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533
[6]   PLASMA TRIGLYCERIDES AND 3 LIPOPROTEIN CHOLESTEROL FRACTIONS ARE INDEPENDENT PREDICTORS OF THE EXTENT OF CORONARY ATHEROSCLEROSIS [J].
DREXEL, H ;
AMANN, FW ;
BERAN, J ;
RENTSCH, K ;
CANDINAS, R ;
MUNTWYLER, J ;
LUETHY, A ;
GASSER, T ;
FOLLATH, F .
CIRCULATION, 1994, 90 (05) :2230-2235
[7]   LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
GRUNFELD, C ;
PANG, MY ;
DOERRLER, W ;
SHIGENAGA, JK ;
JENSEN, P ;
FEINGOLD, KR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1045-1052
[8]   Buffalo hump in men with HIV-1 infection [J].
Lo, JC ;
Mulligan, K ;
Tai, VW ;
Algren, H ;
Schambelan, M .
LANCET, 1998, 351 (9106) :867-870
[9]   Visceral abdominal-fat accumulation associated with use of indinavir [J].
Miller, KD ;
Jones, E ;
Yanovski, JA ;
Shankar, R ;
Feuerstein, I ;
Falloon, J .
LANCET, 1998, 351 (9106) :871-875
[10]   A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial [J].
Montaner, JSG ;
Reiss, P ;
Cooper, D ;
Vella, S ;
Harris, M ;
Conway, B ;
Wainberg, MA ;
Smith, D ;
Robinson, P ;
Hall, D ;
Myers, M ;
Lange, JMA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :930-937